Continuing Education
2025 Substance Misuse Summit
Tuesday, January 14, 2025 at Frazer Church in Montgomery, Alabama
Dr. Ben Carson will serve as keynote speaker.
As part of COACH's commitment to education, faculty are working to provide health care professionals with the knowledge to prevent, recognize, and assist in treatment and referral for opioid use disorders within their practice and community. These education programs bring together a diverse health care audience to encourage communication and collaboration across disciplines. Included in this work is an effort by Drs. Marlowe, Brent Fox, and Haley Phillippe, in partnership with the Alabama Department of Public Health to conduct a series of town hall meetings and summits across the state through the end of 2025 in reference to Alabama's Prescription Drug Monitoring Program, or PDMP. The town halls consist of an interactive PDMP demonstration and skills-building exercise led by Auburn personnel with support from ADPH staff. The summit series is designed to focus broadly on drugs of concern. The role of the PDMP will remain a vital component of this summit series. The 2023 Substance Misuse Summit brought together an interdisciplinary audience of over 280 individuals. As of December 31, 2023, 500+ individuals participated in training provided through this sponsored project. These programs are sponsored by the Alabama Department of Public Health through a parent grant funded by the Department of Justice, Bureau of Justice Assistance.
For more information, visit the COACH website.
This project is supported by Grant No 15PBJA-21-GG-02611-PDMP awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Department of Justice’s Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office for Victims of Crime, and the SMART Office. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the U.S. Department of Justice.
Continuing Education Home Study
We are happy to share a free home study on Alabama's Prescription Drug Monitoring Program. This presentation is a review of the history and laws pertaining to the Alabama PDMP; it provides information to pharmacists and pharmacy technicians needed to successfully submit prescription information to the Alabama PDMP and enhances community pharmacists' understanding and utilization of the Alabama PDMP.
This CE is for pharmacists and pharmacy technicians and is 1.25 hours of continuing education credit.
Alabama's Prescription Drug Monitoring Program: The Essentials
Townhalls
The townhalls consist of an interactive PDMP demonstration and skills-building exercise led by Auburn personnel with support from ADPH staff. Attending can earn you two hours of continuing education.
If you have any questions or issues, please contact the Harrison College of Pharmacy, Office of Alumni and Professional Affairs at [email protected] or Auburn University's Center for Opioid Research, Education, and Outreach at [email protected]. Thank you for your interest in our programs.
The Alabama Health Professionals' Opioid and Pain Management Education (ALAHOPE)
The platform is live at alahope.org.
ALAHOPE is a product of the Prescribers and Dispensers Committee of the Alabama Opioid Overdose and Addiction Council. This work has been a collaboration of the Jefferson County Department of Health, the Department of Health Services Administration at the University of Alabama at Birmingham School of Health Professions, the Alabama Board of Medical Examiners, and multiple subject matter experts from across the state of Alabama. The target populations for this curriculum are health professions students at the undergraduate or graduate level and practicing healthcare professionals.
Physicians, dentists, pharmacists, nurses, and social workers can earn free continuing education credit. This content meets the new educational requirements of DEA-registered practitioners. For more information, see the MATE Training Letter.
This project was supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) Overdose Data to Action cooperative agreement. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS or the U.S. Government.
Page last updated: October 31, 2024
